Sesen Bio Statistics Share Statistics Sesen Bio has 203.49M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 203.49M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 0.01% Shares Floating 187.28M Failed to Deliver (FTD) Shares 2,500 FTD / Avg. Volume 0.2%
Short Selling Information The latest short interest is 2.47M, so 0% of the outstanding
shares have been sold short.
Short Interest 2.47M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 3.25
Valuation Ratios The PE ratio is -0.43 and the forward
PE ratio is null.
Sesen Bio's PEG ratio is
0.
PE Ratio -0.43 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio -0.93 P/FCF Ratio -0.43 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Sesen Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.48,
with a Debt / Equity ratio of -0.09.
Current Ratio 1.48 Quick Ratio 1.48 Debt / Equity -0.09 Debt / EBITDA n/a Debt / FCF -0.04 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.56M Employee Count 17 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0.19% in the
last 52 weeks. The beta is 0.83, so Sesen Bio's
price volatility has been higher than the market average.
Beta 0.83 52-Week Price Change 0.19% 50-Day Moving Average 0.6 200-Day Moving Average 0.61 Relative Strength Index (RSI) 57.6 Average Volume (20 Days) 1,236,121
Income Statement
Revenue n/a Gross Profit n/a Operating Income n/a Net Income -60.48M EBITDA n/a EBIT n/a Earnings Per Share (EPS) -1.46
Full Income Statement Balance Sheet The company has 17.91M in cash and 2.48M in
debt, giving a net cash position of 15.43M.
Cash & Cash Equivalents 17.91M Total Debt 2.48M Net Cash 15.43M Retained Earnings -305.58M Total Assets 5.01M Working Capital -4.66M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -59.92M
and capital expenditures -123K, giving a free cash flow of -60.04M.
Operating Cash Flow -59.92M Capital Expenditures -123K Free Cash Flow -60.04M FCF Per Share -1.45
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields SESN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for SESN.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 8, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Mar 8, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -88.44 Piotroski F-Score 1
